This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Enlivex Therapeutics Ltd. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: Inna Reiner: Pioneering Therapeutic Innovations from Jerusalem
Introduction: Inna Reiner, an accomplished inventor based in Jerusalem, Israel, has made significant strides in the field of therapeutic innovations. With a total of two patents to her name, her research focuses on developing pharmaceutical compositions that aim to tackle complex diseases associated with immune responses.
Latest Patents: Among her latest innovations is a patent for "Therapeutic apoptotic cell preparations, method for producing same and uses thereof." This application provides pharmaceutical compositions comprising a population of mononuclear-enriched cells in an early-apoptotic state. These compositions are designed to treat various conditions characterized by pathological immune responses, including graft versus host disease (GVHD) and a range of autoimmune diseases, such as inflammatory bowel disease, gout, and arthritis. Inna's groundbreaking work in this area showcases her commitment to advancing medical science and improving patient outcomes.
Career Highlights: Inna Reiner's career is marked by her role at Enlivex Therapeutics Ltd., where she plays a crucial part in the company's mission to develop leading-edge therapeutic solutions. Her expertise and dedication in the realm of cell-based therapy empower the company to innovate and lead in the competitive landscape of biomedicine.
Collaborations: Inna collaborates closely with notable professionals in her field, including Dror Mevorach. Together, they work on groundbreaking research and development initiatives that promote innovative treatment methodologies aimed at mitigating severe health conditions.
Conclusion: Inna Reiner's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her inventions and patents not only contribute to the scientific community but also hold the promise of delivering new therapies to patients in need. As she continues her research, Inna remains a pivotal figure in advancing therapeutic solutions from her base in Jerusalem.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile